Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by scarlet1967on May 31, 2021 11:54am
133 Views
Post# 33296302

Egrifta

Egrifta
Good to see some positive exposure…
“WHY IS THE PEPTIDE TESAMORELIN USEFUL?
The Peptide Tesamorelin (Egrifta) is highly successful at reducing abdominal fat accumulation (referred to as visceral adiposity) while preserving lean muscle mass and the metabolic IGF-1 feed-back loop.”
 
https://www.sandcosmetic.com/blog/why-is-the-peptide-tesamorelin-useful/
 
 
As CEO reiterated  Egrifta was launched a head of its time now the relation between abdominal fat which is reduced by Egrifta and serious conditions is more obvious and hopefully the company will create awareness among patients how the drug can protect them from diabetes, atherosclerosis, high blood pressure etc.
 
If you’re concerned about your weight, a more direct and relevant way to gauge potentially unhealthy body fat is to measure your waist circumference, Manson says. This estimates abdominal fat, which lies deep within the abdomen and accumulates around vital organs. In excess, it can increase the risk of certain obesity-related conditions like type 2 diabetes, high blood pressure and coronary artery disease. 
BMI can “label a huge swath of our population as somehow aberrant because of their weight, even if they’re perfectly healthy”, says A Janet Tomiyama, lead author of the study and an associate professor of health psychology at the University of California, Los Angeles.
 
https://www.irishtimes.com/life-and-style/health-family/fitness/is-bmi-good-for-your-health-1.4576824?mode=amp
 
<< Previous
Bullboard Posts
Next >>